ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

DCPC Board Okays Start of Low Fat High Risk Breast Cancer Study, Delays Stage 2 Trial

February 1, 1985

CMS Proposal To Limit ESA Use Is Too Much, Too Fast, Critics Say.

May 18, 2007

NCI T Use Ames Test In Carcinogenesis Testing Program

December 3, 1976

NCCN in Transition: New Strategy to Examine Role of Informatics, Revenue Sources and International Programs

June 15, 2012

Conversation with The Cancer Letter: Scott Soefje: “These are Life-Saving Drugs. I’m Not Going To Stop Treating Patients, Right?”

October 3, 2014

Breast Density As Important As Age In Determining Risk

September 29, 2006